Rachida L.
- Country
- France
- Department
- Médecine Nucléaire
Research Overview
- Multiparametric Dynamic Whole-Body 68Ga-PSMA PET Imaging for Recurrence Detection in Hepatocellular Carcinoma: HIMIKO Study
- Evaluation of 89Zirconium-labelled Girentuximab PET-CT Imaging in Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, and Gastroenteropancreatic Neuroendocrine Neoplasms
- Evaluation of Baricitinib in Combination with Standard Care for Treatment of Large Inflammatory Hepatocellular Adenomas in Histologically Confirmed Patients
Data & Insights
Has run more than one trial at 2 of 14 partner sites.
Specializations
Liver Oncology
The investigator specializes in various forms of liver cancer, with particular emphasis on hepatocellular carcinoma and inflammatory hepatic adenomas. Their research extends to innovative diagnostic and treatment approaches for liver tumors.
- Hepatocellular Carcinoma Management
- Inflammatory Hepatic Adenomas
- Intrahepatic Cholangiocarcinoma
A key focus is on developing novel imaging techniques for liver cancer detection and monitoring.
Advanced Imaging Technologies
The investigator employs cutting-edge imaging methodologies, including PET-CT scanning with specialized tracers for cancer detection. Their work involves multiparametric dynamic whole-body imaging techniques.
- Zirconium-labelled Imaging
- PSMA PET Imaging
- Dynamic Imaging Protocols
These imaging approaches are specifically tailored for hepatic and gastrointestinal malignancies.
Gastrointestinal Oncology
The investigator's expertise includes the study of gastro-entero-pancreatic neuroendocrine neoplasms, representing a comprehensive approach to digestive system cancers.
- Neuroendocrine Tumors
- Targeted Cancer Therapies
- JAK Inhibitor Applications
Their research encompasses both diagnostic and therapeutic aspects of gastrointestinal oncology.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.